A comparison of propofol and amobarbital for use in the Wada test

James A. Magee; Niall P. Pender; Sharon Abrahams; John Thornton; Norman Delanty; Gillian M. Fortune

doi:10.1016/j.seizure.2012.02.001

A comparison of propofol and amobarbital for use in the Wada test

James A. Magee, Niall P. Pender, Sharon Abrahams, John Thornton, Norman Delanty, Gillian M. Fortune

Research output: Contribution to journal › Article › peer-review

Abstract

129 Wada procedures were reviewed to examine the suitability of propofol (n = 54) as a replacement to amobarbital (n = 75) for use as an anaesthetic in the Wada test. Suitability was considered with respect to length of hemiplegia induced, the frequency of side effects and patient memory scores. Data was retrospectively collected from records of patients who had undergone the Wada procedure between 2004 and 2009 in Beaumont Hospital, Dublin. No significant differences were found between the two drugs on any of the measures. The results suggest that propofol represents a suitable alternative to amobarbital for use in the Wada procedure. (C) 2012 Published by Elsevier Ltd on behalf of British Epilepsy Association.

Original language	English
Pages (from-to)	399-401
Number of pages	3
Journal	Seizure - European Journal of Epilepsy
Volume	21
Issue number	5
DOIs	https://doi.org/10.1016/j.seizure.2012.02.001
Publication status	Published - Jun 2012

Access to Document

10.1016/j.seizure.2012.02.001

Cite this

@article{0bf5fbd87781495c860aa89996140ef9,

title = "A comparison of propofol and amobarbital for use in the Wada test",

abstract = "129 Wada procedures were reviewed to examine the suitability of propofol (n = 54) as a replacement to amobarbital (n = 75) for use as an anaesthetic in the Wada test. Suitability was considered with respect to length of hemiplegia induced, the frequency of side effects and patient memory scores. Data was retrospectively collected from records of patients who had undergone the Wada procedure between 2004 and 2009 in Beaumont Hospital, Dublin. No significant differences were found between the two drugs on any of the measures. The results suggest that propofol represents a suitable alternative to amobarbital for use in the Wada procedure. (C) 2012 Published by Elsevier Ltd on behalf of British Epilepsy Association.",

author = "Magee, {James A.} and Pender, {Niall P.} and Sharon Abrahams and John Thornton and Norman Delanty and Fortune, {Gillian M.}",

year = "2012",

month = jun,

doi = "10.1016/j.seizure.2012.02.001",

language = "English",

volume = "21",

pages = "399--401",

journal = "Seizure - European Journal of Epilepsy",

issn = "1059-1311",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - A comparison of propofol and amobarbital for use in the Wada test

AU - Magee, James A.

AU - Pender, Niall P.

AU - Abrahams, Sharon

AU - Thornton, John

AU - Delanty, Norman

AU - Fortune, Gillian M.

PY - 2012/6

Y1 - 2012/6

N2 - 129 Wada procedures were reviewed to examine the suitability of propofol (n = 54) as a replacement to amobarbital (n = 75) for use as an anaesthetic in the Wada test. Suitability was considered with respect to length of hemiplegia induced, the frequency of side effects and patient memory scores. Data was retrospectively collected from records of patients who had undergone the Wada procedure between 2004 and 2009 in Beaumont Hospital, Dublin. No significant differences were found between the two drugs on any of the measures. The results suggest that propofol represents a suitable alternative to amobarbital for use in the Wada procedure. (C) 2012 Published by Elsevier Ltd on behalf of British Epilepsy Association.

AB - 129 Wada procedures were reviewed to examine the suitability of propofol (n = 54) as a replacement to amobarbital (n = 75) for use as an anaesthetic in the Wada test. Suitability was considered with respect to length of hemiplegia induced, the frequency of side effects and patient memory scores. Data was retrospectively collected from records of patients who had undergone the Wada procedure between 2004 and 2009 in Beaumont Hospital, Dublin. No significant differences were found between the two drugs on any of the measures. The results suggest that propofol represents a suitable alternative to amobarbital for use in the Wada procedure. (C) 2012 Published by Elsevier Ltd on behalf of British Epilepsy Association.

U2 - 10.1016/j.seizure.2012.02.001

DO - 10.1016/j.seizure.2012.02.001

M3 - Article

SN - 1059-1311

VL - 21

SP - 399

EP - 401

JO - Seizure - European Journal of Epilepsy

JF - Seizure - European Journal of Epilepsy

IS - 5

ER -

A comparison of propofol and amobarbital for use in the Wada test

Abstract

Access to Document

Fingerprint

Cite this